基因组学市场规模、份额及成长分析（按产品、产品类型、技术、服务类型、应用、研究类型、最终用户和地区）－2025 年至 2032 年产业预测

预计基因组学市场规模在 2023 年将达到 371 亿美元，并将从 2024 年的 416.6 亿美元增长到 2032 年的 1053.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 12.3%。

随着我们对 DNA 结构、功能和图谱的理解不断加深，基因组学领域正在经历重大变革。随着全球癌症发生率的增加，政府对创新基因组学计划的支持力度也越来越大。这种扩散促进了个人化医疗的出现，彻底改变了临床肿瘤学和罕见遗传疾病的治疗策略。同时，学术界正深入研究遗传学与认知障碍的关联性，进一步拓展基因体学的应用领域。对癌症研究的日益关注，加上对快速临床诊断的需求，再加上政府机构和生物製药公司的大力投资，正在推动基因组学市场收益快速成长。这种多方面的演化反映了基因组学对医疗保健和医学科学的深远影响。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 技术分析
• 案例研究

基因组学市场规模（按产品）

• 市场概览
• 产品
• 服务

基因组学市场规模（按产品类型）

• 市场概览
• 试剂、套件及耗材
• 装置
• 生物资讯学工具

基因组学市场规模（按技术）

• 市场概览
• 定序
• PCR
• 基因编辑
• 流式细胞技术
• 微阵列
• 原位杂交
• 其他技术

基因组学市场规模（按服务类型）

• 市场概览
• 基因组分析与定序服务
• 样本和样品製备服务
• 生物资讯服务

基因组学市场规模（按应用）

• 市场概览
• 药物研发
• 诊断
  • 感染疾病
  • 生殖健康
  • 其他诊断应用
  • 农业和动物研究
• 其他用途

基因组学市场规模（依研究类型）

• 市场概览
• 功能基因体学
• 生物标记发现
• 通路分析
• 表观基因
• 其他类型的研究

基因组学市场规模（按最终用户划分）

• 市场概览
• 医院、诊断实验室和诊所
• 学术研究所
• 製药和生物技术公司
• 其他最终用户

基因组学市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Illumina, Inc.（US）
• Thermo Fisher Scientific（US）
• Qiagen NV（Netherlands）
• BGI Group（China）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（US）
• Pacific Biosciences of California, Inc.（US）
• Oxford Nanopore Technologies, Ltd.（United Kingdom）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（US）
• Myriad Genetics, Inc.（US）
• Fluidigm Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• Natera, Inc.（US）
• Veracyte, Inc.（US）
• Personalis, Inc.（US）
• 10x Genomics, Inc.（US）
• Quest Diagnostics（US）

结论和建议

Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The genomics sector is witnessing significant transformation, driven by advancements in the understanding of DNA structure, function, and mapping. As the global incidence of cancer escalates, so does government support, with increased funding fueling innovative genomics projects. This surge has enabled the emergence of personalized medicine, revolutionizing treatment strategies in clinical oncology and rare genetic disorders. Concurrently, academia is delving into the correlations between genetics and cognitive disorders, further expanding genomics applications. The heightened focus on cancer research, coupled with a demand for expedited clinical diagnostics and robust investments from government bodies and biopharmaceutical firms, is propelling the genomics market towards rapid revenue growth. This multifaceted evolution reflects the profound impact genomics has on healthcare and medical sciences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genomics Market Segments Analysis

Global Genomics Market is segmented by Offering, Product Type, Technology, Service Type, Application, Study Type, End User and region. Based on Offering, the market is segmented into Products and Services. Based on Product Type, the market is segmented into Reagents, Kits, And Consumables, Instruments and Bioinformatics Tools. Based on Technology, the market is segmented into Sequencing, PCR, Gene Editing,Flow Cytometry, Microarrays, In Situ Hybridization and Other Technologies. Based on Service Type, the market is segmented into Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services and Bioinformatics Services. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics and Other Applications. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics and Other Study Types. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genomics Market

The Genomics market is experiencing significant growth due to the expanding utilization of Next-Generation Sequencing (NGS) in various applications, particularly in cancer research. This technology encompasses a range of uses, including whole-genome sequencing, the exploration of genomic diversity, metagenomics, epigenetic studies, the identification of non-coding RNAs and protein-binding sites, as well as gene-expression profiling via RNA sequencing. Each of these applications enhances our understanding of genetics and disease, thereby fueling demand in the Genomics market. The increasing reliance on NGS technologies signifies their crucial role in advancing genomic studies and innovations.

Restraints in the Genomics Market

The genomics market is facing potential challenges, particularly regarding the availability of skilled personnel, which is a common constraint in many industries. Additionally, the high costs associated with genomic equipment and the complexities of data storage-stemming from sequenced data between 2023 and 2031-may hinder market growth. While the incorporation of genomic technologies in healthcare has the capacity to improve safety, quality, efficiency, and overall cost-effectiveness, realizing these advantages is heavily contingent upon having access to qualified professionals. Thus, without addressing these limitations, the expansion and effectiveness of the genomics market could be significantly impacted.

Market Trends of the Genomics Market

The genomics market is witnessing a pivotal shift as Illumina phases out its OmniExpress chip in favor of the customized Global Screening Array (GSA) microarray. This transition is compelling companies like Ancestry.com to adapt quickly by either adopting the GSA, integrating Thermo Fisher Scientific products, or investing in next-generation sequencing (NGS) technology. This trend underscores a broader movement within the genomics industry toward enhanced precision, scalability, and cost-effectiveness in genetic analysis. As organizations pivot to maintain competitive advantages, the demand for innovative sequencing solutions is expected to accelerate, driving growth and transformation in the genomics landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Genomics Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Products
• Services

Global Genomics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Reagents, Kits, And Consumables
• Instruments
• Bioinformatics Tools

Global Genomics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing
• PCR
• Gene Editing
• Flow Cytometry
• Microarrays
• In Situ Hybridization
• Other Technologies

Global Genomics Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Genomic Profiling and Sequencing Services
• Sample Preparation and Library Preparation Services
• Bioinformatics Services

Global Genomics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery and Development
• Diagnostics
  • Infectious Diseases
  • Reproductive Health
  • Other Diagnostic Applications
  • Agriculture And Animal Research
• Other Applications

Global Genomics Market Size by Study Type & CAGR (2025-2032)

• Market Overview
• Functional Genomics
• Biomarker Discovery
• Pathway Analysis
• Epigenomics
• Other Study Types

Global Genomics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals, Diagnostic Laboratories, and Clinics
• Academic and Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End Users

Global Genomics Market Size & CAGR (2025-2032)

• North America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • US
  • Canada
• Europe (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies, Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations